Katie Anderson
Katie brings nearly two decades of editorial experience in business-to-business media. After earning her master’s degree in journalism, she began her career at the personal care R&D trade journal Cosmetics & Toiletries. There, she thrived on the constant flow of knowledge gained from interviewing chemists, regulatory experts, formulators and testing professionals in the field.
After nearly eight years with Cosmetics & Toiletries, Katie pursued her passion for skin physiology and ingredient science as Managing Editor of the professional esthetics brand Skin Inc. That same year, she also took on the role of Conference Director for Face and Body, where she developed and managed the event’s educational programming.
Following an acquisition, Katie was promoted to Editor-in-Chief of five professional media brands: Nailpro, Skin Inc., Beauty Launchpad, Medical Esthetics, and WellSpa 360.
Throughout her 19-year editorial career, Katie has held a variety of roles, but her passion has always been scientific editorial. She is the recipient of a bronze Folio Eddie Award for a single science article. She has frequently contributed her expertise as a guest speaker on industry podcasts, webcasts, conferences and video interviews. A lifelong learner, she enjoys the challenge of translating complex technical content into material that is both accurate and accessible.
Connect with Katie on LinkedIn: https://www.linkedin.com/in/katieanderson121/
ARTICLES BY KATIE ANDERSON
-
![Pharmaceutical factory, pills-GettyImages-1419815069]( "FDA Launches PreCheck Program")
FDA Launches PreCheck Program8/12/2025The program introduces a two-phase approach to enable new U.S. drug manufacturing facilities: The Facility Readiness Phase and the Application Submission Phase.
-
![World cancer day, international women day-GettyImages-1410247158]( "Gedatolisib Shatters Phase 3 Goals and Scales For Breast Cancer Breakthrough")
Gedatolisib Shatters Phase 3 Goals and Scales For Breast Cancer Breakthrough8/11/2025After unprecedented phase 3 clinical trails of gedatolisib, Celcuity is working feverishly with its partners to get the drug ready to offer a new standard of care to those that suffer from advanced breast cancer.
-
![expensive healthcare, drug container, pills-GettyImages-171587042]( "President Trump Demands MFN Prices In Manufacturer Letters")
President Trump Demands MFN Prices In Manufacturer Letters8/7/2025President Trump has sent out a letter to 17 major pharmaceutical manufacturers, asking them to commit to lower prices by Sept. 29, 2025, or he plans to deploy every tool in his arsenal to protect American families.
-
![Bristol Myers Squibb office-GettyImages-2160008492]( "Bristol Myers Squibb Forms Immunology Company With Finance Partner")
Bristol Myers Squibb Forms Immunology Company With Finance Partner8/5/2025The NewCo pipeline will start with three clinical-stage and two phase 1-ready investigational medicines that each target mechanisms in autoimmune diseases.
-
![GettyImages-2139576234-partner-team-collaborate-collaboration-meet]( "George Tidmarsh Named CDER Director")
George Tidmarsh Named CDER Director7/24/2025Tidmarsh has over 30 years of experience in biotechnology, clinical medicine, and regulatory science and has authored 143 scientific publications and patents.
-
![GettyImages-1125144281-sanofi]( "Sanofi Expands Immunology Portfolio With Blueprint Acquisition")
Sanofi Expands Immunology Portfolio With Blueprint Acquisition7/24/2025Sanofi expanded its portfolio in immunology with the completed acquisition of Blueprint Medicines Corporation.
-
![250529_AMT-Lab-5626]( "The 3 Big Barriers To AMT Implementation")
The 3 Big Barriers To AMT Implementation7/18/2025Advanced manufacturing technologies (AMTs) can not only lower costs but also improve the quality and consistency of both API and final dosage manufacturing in pharmaceuticals, so why are they not more widely implemented?
-
![FDA Approved GettyImages-1215516118]( "FDA Publishes 200+ CRLs For Increased Transparency")
FDA Publishes 200+ CRLs For Increased Transparency7/16/2025The letters were made available to increase transparency and help sponsors reduce similar mistakes in the future.
-
![250529_AMT-Lab-6158]( "Can AMTs Make U.S. Pharmaceuticals Faster, Better, Stronger?")
Can AMTs Make U.S. Pharmaceuticals Faster, Better, Stronger?7/11/2025As the pharmaceutical industry prepares for impending tariffs and invests in domestic manufacturing, advanced manufacturing technologies present a viable opportunity to modernize systems for improved efficiency, consistent quality and potentially lower costs.
-
![FDA Approved stamp-GettyImages-2196512628]( "FDA Addresses U.S. Health Crisis With Voucher Program")
FDA Addresses U.S. Health Crisis With Voucher Program7/2/2025FDA Commissioner Marty Makary, M.D., M.P.H., tapped into his oncologist experience to launch a new FDA program designed to fast-track the time it takes for important drugs to receive approval and get to patients.
